These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6815756)

  • 21. Medical prevention of ischemic stroke.
    Barnett HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():247-55. PubMed ID: 3159208
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 24. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
    Bousser MG
    Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464
    [No Abstract]   [Full Text] [Related]  

  • 25. [After stroke or TIA. Double protection by second platelet inhibitor].
    MMW Fortschr Med; 2003 Dec; 145(50):57. PubMed ID: 14963978
    [No Abstract]   [Full Text] [Related]  

  • 26. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of the recurrence of episodes of cerebral ischemia. Therapeutic protocol].
    Mazzei B; Carelli A; Gaudio G; Stellato G; Cundari E; Corsonello F
    Minerva Med; 1988 Aug; 79(8):703-6. PubMed ID: 3405477
    [No Abstract]   [Full Text] [Related]  

  • 31. [Controlled cooperative trial. Secondary prevention of atherosclerosis-related cerebral ischemic accidents by aspirin dipyridamole. 2: Description of subjects at the beginning of the trial].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Thibult N; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1982; 138(1):1-15. PubMed ID: 7048482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
    Diener HC
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496
    [No Abstract]   [Full Text] [Related]  

  • 33. [Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
    Marshall M
    Fortschr Med; 1982 May; 100(18):825-30. PubMed ID: 7095698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Platelet function disorders and ischemic cerebral accidents. Therapeutic prospects].
    Géraud J; Rascol A; Bierme R; Boneu B; Guiraud B; Fernet P; Géraud G; David J
    Rev Neurol (Paris); 1972 Jan; 126(1):31-40. PubMed ID: 4635139
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet inhibitors for TIAs. A review of prospective drug trial results.
    Ramirez-Lassepas M
    Postgrad Med; 1984 Apr; 75(5):52-62. PubMed ID: 6369285
    [No Abstract]   [Full Text] [Related]  

  • 36. [Delayed medical treatment of cerebral ischemic accidents. Therapeutic combination of anticoagulants and platelet antiaggregation agents].
    Diez Tejedor E; Barreiro Tella P; Acosta Varo J; Arpa Gutiérrez J
    Arch Neurobiol (Madr); 1980; 43(1):29-44. PubMed ID: 6155890
    [No Abstract]   [Full Text] [Related]  

  • 37. [Secondary prevention after stroke. Doubled performs better].
    MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699837
    [No Abstract]   [Full Text] [Related]  

  • 38. Stroke therapy: status of anti-platelet aggregation drugs.
    Yatsu FM
    Neurology; 1977 Jun; 27(6):503-4. PubMed ID: 325429
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin for transient ischemic attacks.
    Med Lett Drugs Ther; 1980 Aug; 22(17):71-2. PubMed ID: 6995822
    [No Abstract]   [Full Text] [Related]  

  • 40. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
    Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
    Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.